UK drug regulator advises patients and doctors against the use of Pregabalin during pregnancy due to a possible increased risk of congenital malformations.

Pregabalin (Lyrica): findings of safety study on risks during pregnancy – Medicines and Healthcare products Regulatory Agency

See also: Pregabalin and risks in pregnancy – Medicines and Healthcare products Regulatory Agency

Source: Avoid prescribing pregabalin during pregnancy if possible, says UK drug regulator – The BMJ ($)

Commentary on Twitter

The Medicines and Healthcare Products Regulatory Agency (@MHRAgovuk) has strengthened its warning about avoiding pregabalin during pregnancy after new data showed an increased risk of major congenital malformations associated with the drug https://t.co/ghGvqCqA0C

— The BMJ (@bmj_latest) April 22, 2022